Equillium's IPO

Equillium raised a round of funding on October 12, 2018. Investors include Public.

Equillium (NASDAQ:EQ) is a biotechnology company leveraging immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medical need.…

Articles about Equillium's IPO: